These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17325717)

  • 1. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls.
    Barnett JH; Jones PB; Robbins TW; Müller U
    Mol Psychiatry; 2007 May; 12(5):502-9. PubMed ID: 17325717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
    Tsuchimine S; Yasui-Furukori N; Kaneda A; Kaneko S
    PLoS One; 2013; 8(11):e76763. PubMed ID: 24282499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMT Val 158 Met polymorphism is related with interpersonal problem solving in schizophrenia.
    Uçok A; Oztürk M; Duman Z; Saruhan-Direskeneli G
    Eur Psychiatry; 2010 Oct; 25(6):320-2. PubMed ID: 20570494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.
    Cherner M; Watson CW; Saloner R; Halpin LE; Minassian A; Murray SS; Vaida F; Bousman C; Everall I;
    Addict Behav; 2019 Nov; 98():106023. PubMed ID: 31301644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
    Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
    Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
    Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of the functional Catechol-O-Methyltranferase (COMT) Val
    Khanthiyong B; Thanoi S; Reynolds GP; Nudmamud-Thanoi S
    Int J Med Sci; 2019; 16(11):1461-1465. PubMed ID: 31673237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
    Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
    Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study.
    Solís-Ortiz S; Pérez-Luque E; Morado-Crespo L; Gutiérrez-Muñoz M
    Behav Brain Funct; 2010 Oct; 6():67. PubMed ID: 21029471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.
    Fan JB; Zhang CS; Gu NF; Li XW; Sun WW; Wang HY; Feng GY; St Clair D; He L
    Biol Psychiatry; 2005 Jan; 57(2):139-44. PubMed ID: 15652872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.
    Alfimova MV; Golimbet VE; Gritsenko IK; Lezheiko TV; Abramova LI; Strel'tsova MA; Khlopina IV; Ebstein R
    Neurosci Behav Physiol; 2007 Sep; 37(7):643-50. PubMed ID: 17763983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
    Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia.
    Roffman JL; Weiss AP; Deckersbach T; Freudenreich O; Henderson DC; Wong DH; Halsted CH; Goff DC
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):990-5. PubMed ID: 18186041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
    Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
    Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
    Bilder RM; Volavka J; Czobor P; Malhotra AK; Kennedy JL; Ni X; Goldman RS; Hoptman MJ; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Kunz M; Chakos M; Cooper TB; Lieberman JA
    Biol Psychiatry; 2002 Oct; 52(7):701-7. PubMed ID: 12372660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of COMT Val158Met genotype with executive functioning following traumatic brain injury.
    Lipsky RH; Sparling MB; Ryan LM; Xu K; Salazar AM; Goldman D; Warden DL
    J Neuropsychiatry Clin Neurosci; 2005; 17(4):465-71. PubMed ID: 16387984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
    Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
    Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction Between Val158Met Catechol-O-Methyltransferase Polymorphism and Social Cognitive Functioning in Schizophrenia: Pilot Study.
    Tylec A; Jeleniewicz W; Mortimer A; Bednarska-Makaruk M; Kucharska K
    Ann Hum Genet; 2017 Nov; 81(6):267-275. PubMed ID: 28856668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia.
    Greenwood K; Hung CF; Tropeano M; McGuffin P; Wykes T
    Neurosci Lett; 2011 Jun; 496(2):65-9. PubMed ID: 21458532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives.
    Golimbet V; Gritsenko I; Alfimova M; Lebedeva I; Lezheiko T; Abramova L; Kaleda V; Ebstein R
    World J Biol Psychiatry; 2006; 7(4):238-45. PubMed ID: 17071544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.